Home » Posts tagged with » Pharma Industry News

Takeda offers $62bn to acquire Irish rare disease company Shire

Takeda offers $62bn to acquire Irish rare disease company Shire

Japanese pharma company Takeda Pharmaceutical has proposed to acquire Shire, an Ireland-based rare disease company for $62 billion after Botox-maker Allergan scrapped its plans of making a rival bid. Friday’s offer from Takeda Pharmaceutical is the fourth it has made to acquire the rare disease company. Recently, Shire had rejected three offers from the Japanese […]

The post Takeda offers $62bn to acquire Irish rare disease company Shire appeared first on Business News Today.

Procter & Gamble to acquire Merck’s consumer health business for €3.4bn

Procter & Gamble to acquire Merck’s consumer health business for €3.4bn

P&G acquisition of Merck consumer health business : US consumer goods company Procter & Gamble (P&G) has agreed to acquire German pharma company Merck’s consumer health business in an all-cash deal worth around €3.4 billion ($4.2 billion). P&G Acquisition of Merck Consumer Health Business The transaction will help P&G to widen its consumer health business […]

The post Procter & Gamble to acquire Merck’s consumer health business for €3.4bn appeared first on Business News Today.

French pharma company Servier to acquire Shire oncology business for $2.4bn

French pharma company Servier to acquire Shire oncology business for $2.4bn

Pharma acquisition news : French pharma company Servier Laboratories has made a $2.4 billion all-cash deal to acquire the oncology business of Irish biotech company Shire. Servier acquisition of Shire oncology business is expected to help the French pharma company to establish an instant and direct commercial footprint in the US, one of the biggest […]

The post French pharma company Servier to acquire Shire oncology business for $2.4bn appeared first on Business News Today.

Sanofi announces $396m vaccine manufacturing facility in Toronto

Sanofi announces $396m vaccine manufacturing facility in Toronto

French pharma company Sanofi has announced a new vaccine manufacturing facility in Toronto to be built with an investment of CAD500 million ($396.3 million) at the Canadian headquarters of its vaccine business unit Sanofi Pasteur. Sanofi says that the investment in the new vaccine manufacturing plant in Toronto will strengthen its operations in Canada and […]

The post Sanofi announces $396m vaccine manufacturing facility in Toronto appeared first on Business News Today.

Alexion to acquire Swedish pharma company Wilson Therapeutics for $855m

Alexion to acquire Swedish pharma company Wilson Therapeutics for $855m

Pharma acquisition news : US-based Alexion Pharmaceuticals through an all-cash deal of SEK7.1 billion ($855 million) will acquire Wilson Therapeutics, a Swedish pharma company focused on developing drugs for rare copper-mediated disorders such as Wilson disease. Alexion Acquisition of Wilson Therapeutics Alexion Pharmaceuticals has offered to pay SEK232 ($27.84) for each share of the Swedish […]

The post Alexion to acquire Swedish pharma company Wilson Therapeutics for $855m appeared first on Business News Today.

GSK offloads rare disease gene therapy drugs to Orchard Therapeutics

GSK offloads rare disease gene therapy drugs to Orchard Therapeutics

Pharma acquisition news : British drug company GlaxoSmithKline (GSK) has agreed to transfer its rare disease gene therapy drugs to Orchard Therapeutics for an equity stake of 19.9% and a seat on the board of the UK gene therapy company. For some time now, GSK has been mulling to sell the rare disease drug portfolio […]

The post GSK offloads rare disease gene therapy drugs to Orchard Therapeutics appeared first on Business News Today.

Novartis to buy US gene therapy company AveXis for $8.7bn

Novartis to buy US gene therapy company AveXis for $8.7bn

Novartis acquisition of AveXis : Swiss pharma company Novartis has struck a $8.7 billion to acquire US gene therapy company AveXis in a move to bolster its gene therapy and neuroscience pipeline. Novartis Acquisition of AveXis As per the latest pharma acquisition news, Novartis has agreed to pay $218 for each of the AveXis shares. […]

The post Novartis to buy US gene therapy company AveXis for $8.7bn appeared first on Business News Today.

GSK to buy out Novartis’ stake in consumer healthcare JV for $13bn

GSK to buy out Novartis’ stake in consumer healthcare JV for $13bn

Pharma acquisition news : GlaxoSmithKline (GSK) has agreed to buy out Swiss pharma company Novartis’ stake of 36.5% in their consumer healthcare joint venture (JV) for a price of $13 billion, just days after pulling out from a $20 billion race to acquire Pfizer’s consumer healthcare business. Through a 100% ownership in the consumer healthcare […]

The post GSK to buy out Novartis’ stake in consumer healthcare JV for $13bn appeared first on Business News Today.

GSK, Reckitt Benckiser pull out from $20bn race to acquire Pfizer’s consumer healthcare business

GSK, Reckitt Benckiser pull out from $20bn race to acquire Pfizer’s consumer healthcare business

Pharma acquisition news : In a blow to Pfizer’s plans to offload its consumer healthcare business for about $20 billion, both Reckitt Benckiser and now GlaxoSmithKline (GSK) have pulled out from potential acquisition talks with the US pharma giant. Pfizer’s consumer healthcare business comprises a number of over-the-counter (OTC) products that are sold across in […]

The post GSK, Reckitt Benckiser pull out from $20bn race to acquire Pfizer’s consumer healthcare business appeared first on Business News Today.

Danish pharma company Lundbeck to buy Parkinson’s drug developer Prexton

Danish pharma company Lundbeck to buy Parkinson’s drug developer Prexton

Pharma acquisition news : Danish pharma company Lundbeck has reached an agreement, expected to be worth around $1.1 billion, to acquire Prexton Therapeutics, a Swiss pharma company focused on Parkinson’s drug development. As per the terms of Lundbeck acquisition of Prexton, the Danish pharma company will pay around $123 million upfront and later on will […]

The post Danish pharma company Lundbeck to buy Parkinson’s drug developer Prexton appeared first on Business News Today.

Page 1 of 41234